Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Shukra Pharmaceuticals Limited
Founded in 1993, Shukra Pharmaceuticals Limited has been operating for more than 33 years. Shukra Pharmaceuticals Limited is registered with CIN L24231GJ1993PLC019079 (reg. no. 19079). This entity is incorporated as company limited by shares. The firm’s authorized share capital totals ₹44.00 crore. Shukra Pharmaceuticals Limited’s paid-up capital stands at ₹43.79 crore.
The company’s main operations are related to manufacture of chemicals and chemical products. The company has been registered in the city of Ahmedabad. Its official registered office is situated at 3rd Floor, Dev House, Opp. Wiaa Office, Judges Bungalows Road, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380003. Shukra Pharmaceuticals Limited remains active and operational. The Permanent Account Number assigned to the company is AAACR5476N. The entity’s LEI (Legal Entity Identifier) number is 984500650D08AFF75E91. Its primary communication email is info@shukrapharmaceuticals.com. Senior management roles are held by Anar Jayeshbhai Patel (CFO).
Company Overview
- CIN
- Date of Incorporation
- 04/03/1993
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹44,00,00,000.00
- Paid up Capital
- ₹43,78,79,440.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- info@shukrapharmaceuticals.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Gujarat | 24AAACR5476N2ZX | Active |
| 24AAACR5476N1ZY | Active | |
| 24AAACR5476N3ZW | Active | |
| Haryana | 06AAACR5476N1ZW | Active |
| Karnataka | 29AAACR5476N1ZO | Active |
| Maharashtra | 27AAACR5476N1ZS | Active |
| Uttar Pradesh | 09AAACR5476N1ZQ | Active |
| West Bengal | 19AAACR5476N1ZP | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE551C13015 | SHUKRA PHARMACEUTICALS LIMITED WARRANTS 28JL27 | - | 28/07/2027 | SHUKRA PHARMACE/WT 20270728 | RWSTBA |
| IN8551C01043 | SHUKRA PHARMACEUTICALS LIMITED EQ PP RS 2.5/- LISTING/TRDG APRVL AWAITED | - | 12/10/2026 | SHUKRA PHARMACE/SH VTG | ESVUPN |
| INE551C01044 | SHUKRA PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | - | 12/10/2026 | SHUKRA PHARMACE/SH VTG | ESVUFN |
| INE551C20028 | SHUKRA PHARMACEUTICALS LIMITED REs-EQ PP RS 2.5/- | - | 12/10/2026 | SHUKRA PHARMACE/ENTL RT | RSSXXN |
| IN8551C01068 | SHUKRA PHARMACEUTICALS LIMITED EQ NEW FV RE. 1/-LISTING/TRADG APRVL AWAITED | - | 12/10/2026 | SHUKRA PHARMACE/SH VTG | ESVUFN |
| IN9551C01026 | SHUKRA PHARMACEUTICALS LIMITED EQ PP RS 2.5/- | - | 12/10/2026 | SHUKRA PHARMACE/SH VTG PP | ESVUPN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹3,363.01L | ₹2,134.27L | ₹2,160.45L | ₹2,189.47L | ₹0.00L |
| Gross PPE | ₹3,363.01L | ₹4,573.18L | ₹4,298.87L | ₹4,122.87L | ₹0.00L |
| Inventory | ₹1,390.34L | ₹995.30L | ₹231.44L | ₹315.67L | ₹0.00L |
| Total Debt | ₹501.95L | ₹417.67L | ₹315.39L | ₹508.16L | ₹0.00L |
| Common Stock | ₹4,378.79L | ₹4,378.79L | ₹1,094.70L | ₹391.42L | ₹0.00L |
| Current Debt | ₹182.66L | ₹106.38L | ₹49.72L | ₹131.32L | ₹0.00L |
| Share Issued | ₹4,378.79L | ₹4,378.79L | ₹4,378.79L | ₹720.21L | ₹0.00L |
| Total Assets | ₹11,744.00L | ₹8,676.98L | ₹7,783.71L | ₹7,496.64L | ₹0.00L |
| Capital Stock | ₹4,378.79L | ₹4,378.79L | ₹1,094.70L | ₹391.42L | ₹0.00L |
| Long Term Debt | ₹319.29L | ₹311.29L | ₹265.67L | ₹376.84L | ₹0.00L |
| Current Assets | ₹8,380.99L | ₹6,542.72L | ₹5,623.26L | ₹5,307.17L | ₹0.00L |
| Working Capital | ₹6,071.75L | ₹4,814.36L | ₹4,207.94L | ₹1,056.55L | ₹0.00L |
| Invested Capital | ₹9,486.85L | ₹6,701.24L | ₹6,078.82L | ₹3,037.83L | ₹0.00L |
| Other Properties | ₹2,172.31L | ₹1,939.72L | ₹36.15L | ₹36.15L | ₹0.00L |
| Common Stock Equity | ₹8,984.90L | ₹6,283.57L | ₹5,763.43L | ₹2,529.67L | ₹0.00L |
| Net Tangible Assets | ₹8,984.90L | ₹6,283.57L | ₹5,763.43L | ₹2,529.67L | ₹0.00L |
| Tangible Book Value | ₹8,984.90L | ₹6,283.57L | ₹5,763.43L | ₹2,529.67L | ₹0.00L |
| Current Liabilities | ₹2,309.24L | ₹1,728.36L | ₹1,415.32L | ₹4,250.62L | ₹0.00L |
| Stockholders Equity | ₹8,984.90L | ₹6,283.57L | ₹5,763.43L | ₹2,529.67L | ₹0.00L |
| Other Equity Interest | ₹4,606.11L | ₹1,904.79L | ₹4,669.26L | ₹2,138.26L | ₹0.00L |
| Total Capitalization | ₹9,304.19L | ₹6,594.86L | ₹6,029.10L | ₹2,906.51L | ₹0.00L |
| Ordinary Shares Number | ₹4,378.79L | ₹4,378.79L | ₹4,378.79L | ₹720.21L | ₹0.00L |
| Total Non Current Assets | ₹3,363.01L | ₹2,134.26L | ₹2,160.45L | ₹2,189.47L | ₹0.00L |
| Cash And Cash Equivalents | ₹597.63L | ₹1,211.77L | ₹998.03L | ₹397.31L | ₹0.00L |
| Construction In Progress | ₹1,190.70L | ₹230.69L | ₹202.32L | ₹166.17L | ₹0.00L |
| Other Non Current Liabilities | ₹0.01L | ₹0.02L | ₹0.53L | ₹10.83L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹8,984.90L | ₹6,283.57L | ₹5,763.43L | ₹2,529.67L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,759.10L | ₹2,393.41L | ₹2,020.28L | ₹4,966.97L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹182.66L | ₹106.38L | ₹49.72L | ₹131.32L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹319.29L | ₹311.29L | ₹265.67L | ₹376.84L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹597.63L | ₹1,211.77L | ₹998.03L | ₹397.31L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹449.86L | ₹665.05L | ₹604.96L | ₹716.35L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | -₹1,179.89L | ₹517.54L | -₹695.68L | -₹132.15L | ₹0.00L |
| Changes In Cash | -₹614.15L | ₹213.73L | ₹600.73L | ₹368.35L | ₹0.00L |
| End Cash Position | ₹597.63L | ₹1,211.77L | ₹998.04L | ₹397.31L | ₹0.00L |
| Financing Cash Flow | ₹407.03L | -₹451.75L | ₹1,240.50L | ₹494.11L | ₹0.00L |
| Investing Cash Flow | -₹1,414.31L | -₹126.36L | -₹120.09L | -₹442.71L | ₹0.00L |
| Operating Cash Flow | ₹393.13L | ₹791.84L | -₹519.68L | ₹316.95L | ₹0.00L |
| Capital Expenditure | -₹1,573.02L | -₹274.30L | -₹176.00L | -₹449.10L | ₹0.00L |
| Beginning Cash Position | ₹1,211.77L | ₹998.04L | ₹397.29L | ₹28.96L | ₹0.00L |
| Issuance Of Capital Stock | ₹539.26L | -₹59.49L | ₹1,387.19L | ₹462.79L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.00L | ₹0.02L | ₹0.00L | ₹0.01L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹2,987.99L | ₹1,393.15L | ₹2,015.97L | ₹469.73L | ₹0.00L |
| EBITDA | ₹3,332.26L | ₹1,693.64L | ₹2,220.99L | ₹653.48L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹4,087.84L | ₹2,447.56L | ₹3,008.65L | ₹1,351.70L | ₹0.00L |
| Pretax Income | ₹2,878.69L | ₹1,333.66L | ₹1,988.34L | ₹444.17L | ₹0.00L |
| Tax Provision | ₹672.84L | ₹376.14L | ₹134.61L | ₹3.52L | ₹0.00L |
| Total Revenue | ₹5,672.74L | ₹3,258.73L | ₹7,457.29L | ₹5,883.36L | ₹0.00L |
| Cost Of Revenue | ₹1,584.90L | ₹811.17L | ₹4,448.64L | ₹4,531.66L | ₹0.00L |
| Total Expenses | ₹3,143.23L | ₹2,286.24L | ₹5,721.98L | ₹5,530.77L | ₹0.00L |
| Interest Expense | ₹109.30L | ₹59.49L | ₹27.63L | ₹25.56L | ₹0.00L |
| Operating Income | ₹2,529.51L | ₹972.49L | ₹1,735.31L | ₹352.59L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹3,332.26L | ₹1,693.64L | ₹2,196.05L | ₹609.86L | ₹0.00L |
| Normalized Income | ₹2,205.84L | ₹957.51L | ₹1,830.47L | ₹397.38L | ₹0.00L |
| Operating Expense | ₹1,558.33L | ₹1,475.07L | ₹1,273.34L | ₹999.11L | ₹0.00L |
| Operating Revenue | ₹5,672.74L | ₹3,258.73L | ₹7,457.29L | ₹5,883.36L | ₹0.00L |
| Net Interest Income | -₹109.30L | -₹59.49L | ₹27.41L | -₹21.69L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹24.94L | ₹43.62L | ₹0.00L |
| Basic Average Shares | ₹4,411.68L | ₹4,352.32L | ₹4,378.79L | ₹3,231.49L | ₹0.00L |
| Diluted Average Shares | ₹4,411.68L | ₹4,352.32L | ₹4,378.79L | ₹3,231.49L | ₹0.00L |
| Other Operating Expenses | ₹510.34L | ₹563.57L | ₹162.47L | ₹199.05L | ₹0.00L |
| Reconciled Depreciation | ₹344.27L | ₹300.49L | ₹205.02L | ₹183.75L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹1,584.90L | ₹811.17L | ₹4,448.64L | ₹4,531.66L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹1.69L | ₹0.35L | ₹0.00L |
| Interest Expense Non Operating | ₹109.30L | ₹59.49L | ₹27.63L | ₹25.56L | ₹0.00L |
| Net Income Common Stockholders | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
| Net Income Continuous Operations | ₹2,205.85L | ₹957.52L | ₹1,853.73L | ₹440.65L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹24.94L | ₹43.62L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹109.30L | -₹59.49L | ₹27.41L | -₹21.69L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹2,205.84L | ₹957.51L | ₹1,853.72L | ₹440.65L | ₹0.00L |
Company Performance (FY23–FY26)
₹74.6 Cr₹55.9 Cr₹37.3 Cr₹18.6 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 23/05/2012 | Payal Sujay Mehta | 02145421 | Director | View other directorships |
| 26/05/2012 | Dakshesh Rameshchandra Shah | 00561666 | Managing Director | View other directorships |
| 16/01/2019 | Bhoomiben Patel | 08316893 | Director | View other directorships |
| 04/01/2021 | Arpita Kabra | *****6544M | Company Secretary | |
| 12/08/2023 | Sonal Deepalbhai Gandhi | 07351479 | Director | View other directorships |
| 16/08/2023 | Sanskruti Jayeshbhai Patel | 07108631 | Whole-time director | View other directorships |
| 16/08/2023 | Sarjeevan Singh | 08258683 | Director | View other directorships |
| 16/08/2023 | Dhruvin Shah | 08801616 | Whole-time director | View other directorships |
| 25/11/2023 | Pinki Nirmal Sagar | 08113318 | Director | View other directorships |
| 10/07/2024 | Anar Jayeshbhai Patel | 02588388 | Whole-time director | View other directorships |
| 10/07/2024 | Jitendra Somchand Shah | 01609325 | Director | View other directorships |
| 10/07/2024 | Anar Jayeshbhai Patel | *****8690E | CFO | |
| 25/10/2024 | Shital Shah | 00561649 | Additional Director | View other directorships |
| 25/10/2024 | Ritu Kapoor | 10334249 | Additional Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 14
- Dakshesh Rameshchandra ShahManaging Director
- Anar Jayeshbhai PatelWhole-time director
- Dhruvin ShahWhole-time director
- Sanskruti Jayeshbhai PatelWhole-time director
- Jitendra Somchand ShahDirector
- Pinki Nirmal SagarDirector
- Sarjeevan SinghDirector
- Sonal Deepalbhai GandhiDirector
- Bhoomiben PatelDirector
- Payal Sujay MehtaDirector
- Ritu KapoorAdditional Director
- Shital ShahAdditional Director
- Anar Jayeshbhai PatelCFO
- Arpita KabraCompany Secretary
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/12/2024 | Form MGT-7-28112024 | - |
| 10/11/2024 | Form AOC-4(XBRL)-10112024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
3rd Floor, Dev House, Opp. Wiaa Office, Judges Bungalows Road, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380003
Frequently Asked Questions
What is the incorporation date of Shukra Pharmaceuticals Limited?
The incorporation date of Shukra Pharmaceuticals Limited is 04/03/1993.
What is the authorized share capital and paid-up capital of Shukra Pharmaceuticals Limited?
The authorized share capital of Shukra Pharmaceuticals Limited is ₹44,00,00,000.00. The paid-up capital is ₹43,78,79,440.00.
Who are the current board members & directors of Shukra Pharmaceuticals Limited?
The current board member of Shukra Pharmaceuticals Limited are:
- Bhoomiben Patel
- Dakshesh Rameshchandra Shah
- Payal Sujay Mehta
- Shital Shah
- Ritu Kapoor
- Anar Jayeshbhai Patel
- Jitendra Somchand Shah
- Pinki Nirmal Sagar
- Sonal Deepalbhai Gandhi
- Sanskruti Jayeshbhai Patel
- Sarjeevan Singh
- Dhruvin Shah
What is the registered address of Shukra Pharmaceuticals Limited?
The registered address of Shukra Pharmaceuticals Limited is 3rd Floor, Dev House, Opp. Wiaa Office, Judges Bungalows Road, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380003.
What is the Corporate Identification Number of Shukra Pharmaceuticals Limited?
The Corporate Identification Number of Shukra Pharmaceuticals Limited is L24231GJ1993PLC019079.